NEUROCRINE BIOSCIE revenue breakdown overview

NEUROCRINE BIOSCIE revenue for the last year amounted to 1.59 B CHF, the most of which — 1.59 B CHF — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 1.38 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought NEUROCRINE BIOSCIE 1.59 B CHF, and the year before that — 1.38 B CHF.